Skip to search formSkip to main contentSkip to account menu

cimoxatone

Known as: 3-(4-(3-cyanophenylmethoxy)phenyl)-5-(methoxymethyl)-2-oxazolidinone, Benzonitrile, 3-((4-(5-(methoxymethyl)-2-oxo-3-oxazolidinyl)phenoxy)methyl)- 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

MD 780515

Broader (2)

Monoamine Oxidase InhibitorsOxazolidinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Pharmacokinetic and relative bioavailability studies of cimoxatone in humans.
The pharmacokinetics of the reversible MAO-A inhibitor, cimoxatone, and its O-demethyl metabolite MD 770222 were investigated in… 
1983
1983
The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222
SummaryIn both rat brain and heart, noradrenaline and 5-hydroxytryptamine are metabolised predominantly by monoamine oxidase-A… 
1983
1983
[Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
Cimoxatone is a new monoamine oxidase inhibitor (MAOI) in comparison to the existing non-selective and irreversible MAOIs used in… 
1983
1983
Estimation of the elimination half-life of the monoamine oxidase inhibitor cimoxatone in rat brain on the basis of ex vivo inhibition data
SummaryCimoxatone is a reversible mixed-type selective inhibitor of monoamine oxidase-A. For a mixed-type inhibitor, it can be… 
1983
1983
High-performance liquid chromatographic determination of cimoxatone and its O-demethyl metabolite in plasma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)